대유행 인플루엔자(H1N1 2009) 급성호흡곤란증후군에 대한 체외막 산소화 장치의 조기적용 1례
Early Extracorporeal Membrane Oxygenation in a Patient with Pandemic Influenza (H1N1 2009) and Acute Respiratory Distress Syndrome
1
조회
0
다운로드
2
인용
0
참고문헌
키워드
초록
Despite advanced technologies in intensive care, pandemic influenza (H1N12009) can rapidly progress to acute respiratory distress syndrome (ARDS)and cause death in a small subset of patients. Extracorporeal membrane oxygenation (ECMO) is expected to provide adequate gas exchange, to reduce ventilator-induced lung injury and, eventually, to improve outcome in these patients. A previously healthy, young female received mechanically ventilatory support because of rapidly progressive respiratory failure caused by 2009H1N1 influenza. As she failed to respond to high ventilatory support, ECMO was instituted at 6 hours after admission. We describe detailed course of case and literature review on ECMO, helping physicians make a decision to initiate ECMO in patients with influenza-related ARDS.
Abstract
Despite advanced technologies in intensive care, pandemic influenza (H1N12009) can rapidly progress to acute respiratory distress syndrome (ARDS)and cause death in a small subset of patients. Extracorporeal membrane oxygenation (ECMO) is expected to provide adequate gas exchange, to reduce ventilator-induced lung injury and, eventually, to improve outcome in these patients. A previously healthy, young female received mechanically ventilatory support because of rapidly progressive respiratory failure caused by 2009H1N1 influenza. As she failed to respond to high ventilatory support, ECMO was instituted at 6 hours after admission. We describe detailed course of case and literature review on ECMO, helping physicians make a decision to initiate ECMO in patients with influenza-related ARDS.
참고문헌 (12)
- Perez-Padilla R, "INER Working Group on Influenza. Pneumonia and respiratory failure from swine-origin influenza A (H1N1) in Mexico", N Engl J Med, 361, pp.680~689 (2009)
- Zapol WM, "Extracorporeal membrane oxygenation in severe acute respiratory failure. A randomized prospective study", JAMA, 242, pp.2193~2196 (1979)
- Morris AH, "Randomized clinical trial of pressure-controlled inverse ratio ventilation and extracorporeal CO2 removal for adult respiratory distress syndrome", Am J Respir Crit Care Med, 149, pp.295~305 (1994)
- , 2010
- Kumar A, "Canadian Critical Care Trials Group H1N1 Collaborative. Critically ill patients with 2009 influenza A(H1N1) infection in Canada", JAMA, 302, pp.1872~1879 (2009)
- Jain S, "2009 Pandemic Influenza A (H1N1) Virus Hospitalizat ions Invest igat ion Team. Hospitalized patients with 2009 H1N1 influenza in the United States, April-June 2009", N Engl J Med, 361, pp.1935~1944 (2009)
- Echevarria-Zuno S, "Infection and death from influenza A H1N1 virus in Mexico: a retrospective analysis", Lancet, 374, pp.2072~2079 (2009)
- Brun-Buisson C, "ALIVE Study Group. Epidemiology and outcome of acute lung injury in European intensive care units. Results from the ALIVE study", Intensive Care Med, 30, pp.51~61 (2004)
- Peek GJ, "Efficacy and economic assessment of conventional ventilatory support versus extracorporeal membrane oxygenation for severe adult respiratory failure (CESAR): a multicentre randomised controlled trial", Lancet, 374, pp.1351~1363 (2009)
- Australia and New Zealand Extracorporeal Membrane Oxygenation (ANZ ECMO) Influenza Investigators, "Extracorporeal membrane oxygenation for 2009 influenza A(H1N1) acute respiratory distress syndrome", JAMA, 302, pp.1888~1895 (2009)
- Conrad SA, "Extracorporeal Life Support Registry Report 2004", ASAIO J, 51, pp.4~10 (2005)
- Lewandowski K, "Extracorporeal membrane oxygenation for severe acute respiratory failure", Crit Care, 4, pp.156~168 (2000)